Skip to main content
NCBI home page
Veterinary Medicine and Science logoLink to Veterinary Medicine and Science
. 2023 Dec 8;10(1):e1320. doi: 10.1002/vms3.1320

The risk of pet animals in spreading severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and public health importance: An updated review

Sina Salajegheh Tazerji 1,2,✉, Rasha Gharieb 3, Mohammadreza Manouchehri Ardestani 4, Baharak Akhtardanesh 5, Farrokhreza Kabir 1, Bita Vazir 6, Phelipe Magalhães Duarte 7, Niloufar Saberi 1, Ehsan Khaksar 8, Sadegh Haerian 9, Mohamed Fawzy 10
PMCID: PMC10766024  PMID: 38066661

Abstract

Since the outbreak of SARS‐CoV‐2 was first identified in 2019, it has been reported that the virus could infect a variety of animals either naturally or experimentally. This review discusses the occurrence SARS‐CoV‐2 in dogs and cats and the role of these animals in transmitting coronavirus disease 2019 (COVID‐19) to their owners. The data were collected from epidemiological studies and case reports that focused on studying the occurrence of SARS‐CoV‐2 in pet animals and their owners. Epidemiological studies and case reports indicate that dogs and cats are infected with SARS‐CoV‐2 either naturally or experimentally; however, the global number of naturally infected animals is far lower than the number of people who have COVID‐19. These studies demonstrate that pet animals acquire the infection from direct contact with COVID‐19‐infected owners. Currently, there are no studies reporting that dogs and cats can transmit SARS‐CoV‐2 to other animals and humans, under natural conditions. The emergence of SARS‐CoV‐2 infection in companion animals (dogs and cats) in different countries worldwide raises concerns that pets are at higher risk for spreading and transmitting SARS‐CoV‐2 to humans and other animals, which poses a hazard to the public health. Therefore, investigating the role of dogs and cats in the transmission and epidemiology of SARS‐CoV‐2 will help us to design and implement appropriate preventive measures against the further transmission of SARS‐CoV‐2.

Keywords: cats, dogs, one health, SARS‐CoV‐2, Zoonoses

Dogs and cats are infected with SARS‐CoV‐2 either naturally or experimentally.

SARS‐CoV‐2 can be transmitted to dogs and cats through close contact with coronavirus disease 2019 (COVID‐19) infected owners.

COVID‐19‐infected owners should limit close contact with their pets and follow hygienic measures.

graphic file with name VMS3-10-e1320-g001.jpg

1. INTRODUCTION

SARS‐CoV‐2 is a newly emerged Coronavirus responsible for the current coronavirus disease 2019 (COVID‐19), which causes respiratory infections in humans worldwide. It is an enveloped, positive‐sense single‐stranded RNA virus that belongs to family Coronaviridae, genus Betacoronavirus (Chen et al., 2020b). The virus was initially discovered in the Wuhan Province, China in late 2019 (Bogoch et al., 2020; Zhou et al., 2020). Phylogenetic studies and genomic analysis of SARS‐CoV‐2 and its closest relatives showed that SARS‐CoV‐2, which is the causal agent of COVID‐19, has 96.2% overall genome sequence identity with bat CoV RaTG13 (Zhou et al., 2020). SARS‐CoV‐2 could be potentially transmitted to a human population, quickly adapted to humans, and human‐to‐human transmission becomes an almost immediate source of subsequent infection through direct contact and aerosol droplets (Li et al., 2020). Importantly, several studies worldwide reported that dogs and cats can be naturally (Bosco‐Lauth et al., 2020; Elaswad et al, 2020; Fritz et al., 2020; Gaudreault et al., 2020; Halfmann et al., 2020; Musso et al., 2020; Newman et al., 2020; Salajegheh Tazerji et al., 2020; Zhang et al., 2020) and experimentally (Shi et al., 2020) infected with SARS‐CoV‐2. The close association between humans and their pets raises concerns about the potential risks of transmission of SARS‐CoV‐2 from COVID‐19‐infected owners to their pets (reverse zoonosis) and the potential role of infected animals in spreading the disease (Leroy et al, 2020). Previous studies in Hong Kong (Sit et al., 2020), Brazil (Calvet et al., 2021), Latin America (Carlos et al., 2021), Italy (Patterson et al., 2020), France (Sailleau et al., 2020) and Spain (Segalés et al., 2020) demonstrated that SARS‐CoV‐2 infection is mostly detected in dogs and cats residing in households with SARS‐CoV‐2 infected owners, suggesting that human to pet transmission may have occurred. Currently, The World Health Organization (WHO), the World Organization for Animal Health, the World Small Animal Veterinary Association, as well as other human and animal health organizations indicate that there is no scientific evidence that companion animals like dogs and cats can transmit SARS‐CoV‐2 to humans. The animal origin of the SARS‐CoV‐2 led to a debate about the possible transmission of the disease to humans through animals. The investigation of the reservoir and intermediate hosts for SARS‐CoV‐2 can help in understanding the epidemiology and dynamics of the COVID‐19 pandemics, which raises the alarm that infected animals may become potential transmitters to humans. Dogs and cats are the most common species kept as household pets, thus this review discusses susceptibility of dogs and cats to infection with SARS‐CoV‐2 with a particular focus on possible transmission routes and the appropriate preventive and control measures based on One‐Health approaches.

2. CORONAVIRUSES PATHOTYPES IN DOGS AND CATS

Coronaviruses (CoVs) are enveloped, single‐stranded and positive‐sense RNA viruses that belong to the subfamily orthocoronavirinae, family coronaviridae, order Nidovirales and subfamily Coronavirinae, which includes four genera: Alpha‐, Beta‐, Gamma‐ and Delta CoVs. CoVs are identified in several species of mammals and humans (Cohen et al, 2013).

2.1. Coronaviruses in dogs

Dogs are infected with two types of CoVs: Canine CoVs (CCoVs), which belonged to genus Alpha CoVs, and Canine respiratory CoVs (CRCoVs), which belonged to genus Beta CoVs. CCoVs are classified into two genotypes (I and II) based on variations in spike (S) protein amino acid sequences (Licitra et al, 2014). Both CCoVs genotypes (I and II) are restricted to the gastrointestinal tract of infected dogs and known to cause enteric infections. The symptoms are generally mild and self‐limiting in the absence of co‐infecting pathogens such as parvovirus; however, gastroenteritis may occur (Buonavoglia et al., 2006; Erles et al, 2003). Also, there is a highly virulent biotype of CCoVs, which belonged to CCoV‐IIa genetic cluster and was designated as pantropic CCoV due to its systemic distribution in internal organs. Young puppies are more likely to experience the more severe pantropic CCoV symptoms characterized by fever, lethargy, haemorrhagic diarrhoea, severe lymphopenia and neurological signs followed by death (Buonavoglia et al., 2006; Decaro et al., 2007). In wild carnivorous, CCoVs were detected in wolves (Canis lupus), red foxes (Vulpes vulpes), Eurasian otters (Lutra lutra) and common genets (Genetta genetta). CRCoV infections in dogs are associated with mild respiratory signs, though severe clinical signs have been reported (Erles et al., 2003).

2.2. Coronaviruses in cats

Feline CoVs (FCoVs), which belong to genus Alpha CoVs are classified into two antigenically distinct serotypes (FCoVs I and II) and known to infect domestic and wild felids (Jaimes et al, 2020; Pedersen, 2014). Based on pathobiology and virulence, FCoVs can have either a low‐virulent enteric pathotype (feline enteric coronavirus; FECV) or a high‐virulent pathotype (feline infectious peritonitis virus; FIPV). FECV‐infected cats usually exhibit mild or subclinical symptoms during the initial viral infection but may occasionally experience transient episodes of diarrhoea and/or mild upper respiratory signs from which they recover spontaneously (Brown et al, 2009). However, FECV has the potential to be converted to a highly virulent circulating form (FIPV) if the virus mutates during replication in macrophages. FIPV that has a higher propensity to cause severe to lethal feline infectious peritonitis (FIP) (Brown et al., 2009). FIP is often observed in young cats, which has two progressive and ultimately fatal forms: The wet/effusive form associated with the accumulation of a characteristic viscous yellow fluid in body cavities and the dry/non‐effusive form with pyogranulomatous lesions affecting several organs (Kipar & Meli, 2014; Pedersen, 2014). FIP is complicated by antibody‐dependent enhancement of infection, where sub‐neutralizing antibodies can recognize the virus spike protein, enhancing macrophage infection and leading to more rapid disease progression (Takano et al, 2008). CCoVs can be transmitted easily to humans through droplets, whereas transmission of FCoVs to humans is highly limited (Jaimes & Whittaker, 2018).

3. OCCURRENCE OF SARS‐COV‐2 IN DOGS AND CATS

SARS‐CoV‐2 initially emerged in late 2019 in Wuhan City, China, with a symptomatic infection or severe pneumonia in individuals that resulted in mortality and was termed COVID‐19 by WHO (Tan et al., 2020; Zhu et al., 2020). Several studies investigated the occurrence of SARS‐CoV‐2 in dogs and cats (Table 1). SARS‐CoV‐2 was identified in dogs and cats living in the same households with COVID‐19‐infected owners (Table 1). However, there is no substantial evidence to date that dogs and cats can transmit SARS‐CoV‐2 to humans. The genetic relationship between SARS‐CoV‐2 recovered from infected cats, dogs and their owners residing in the same households was determined in previous studies (Table 1). A high genetic similarity with 99.8% (Barrs et al., 2020) and 99.4% (Carlos et al., 2021) was reported between SARS‐CoV‐2 genomic sequences in household cats and their owners. Furthermore, the genomic sequences of SARS‐CoV‐2 from dogs in Hong Kong, China shared a high genetic similarity (100%) with SARS‐CoV‐2 from infected owners (Sit et al., 2020).

TABLE 1.

Reports of SARS‐CoV‐2 natural infection in dogs and cats worldwide.

Species Country Clinical signs Sample Tests Positive/total animals (%) Dogs/Cats are living in the same household with COVID‐19‐infected owners Identity between the genomic sequences of SARS‐CoV‐2 in pets and their owners References
Dog Hong Kong, China No

Oral and faecal swab

Serum samples

RT‐qPCR

PRN

 1/1 (100.0) Yes NA WHO (2022)
Dog Hong Kong, China No

Nasal and oral swabs

Serum samples

RT‐qPCR

PRN

 1/1 (100.0) Yes NA WHO (2022)
Dog Croatia No Serum samples Serological tests 2/654 (0.31) Yes NA Stevanovic et al. (2021)
Dog Hong Kong, China No Nasal, oral, rectal swabs and serum samples

RT‐qPCR

PRN

 2/15 (13.3) Yes 100% Sit et al. (2020)
Dog Italy Yes Oropharyngeal, nasal, rectal swabs and serum samples RT‐qPCR, PRN 6/47 (12.8) Yes NA Patterson et al. (2020)
Dog Wuhan, China No

Oral, rectal swabs

Serum samples

RT‐qPCR

PRN

Serological tests

 1/9 (11.1) Yes NA Chen et al. (2020a)
Dog France Yes Nasopharyngeal, rectal swabs and serum samples RT‐qPCR, serological tests 0/12 (0) Yes NA Sailleau et al. (2020)
Dog La Rioja, northern Spain No Oropharyngeal and rectal swabs RT‐qPCR 0/12 (0) Yes NA Ruiz‐Arrondo et al. (2021)
Dog Thailand Yes Serum samples Serological tests 35/2103 (1.66) No NA Udom et al. (2022)
Dog France No Serum samples Serological tests 2/13 (15.4) Yes NA Fritz et al. (2020)
Dog Rio de Janeiro, Brazil Yes Nasopharyngeal, oropharyngeal, rectal swabs and serum samples RT‐qPCR, PRN 9/29 (31) Yes NA Calvet et al. (2021)
Dog

New York State,

Richmond

, USA

 Yes Serum samples Serological tests 2/2 (100.0) Yes NA Cima and Behravesh (2021)
Dog Brazos, Texas, USA No Nasal/Nasopharyngeal, oral/oropharyngeal, rectal swabs and serum samples RT‐qPCR, serological tests 1/59 (1.7) Yes NA Hamer et al. (2020)
Cat Wuhan, China No Nasopharyngeal and anal swabs, serum samples Serological tests 3/15 (20) Yes NA Zhang et al. (2020)
Cat Croatia No Serum samples Serological tests 1/131 (0.76) Yes NA Stevanovic et al. (2021)
Cat Hong Kong, China No Nasal, oral and rectal swabs

RT‐qPCR

PRN

 6/50 (12) Yes 99.8% Barrs et al. (2020)
Cat Hong Kong/China No Nasal, oral and faecal Swabs RT‐qPCR 1/17 (5.9) Yes NA AVMA (2020)
Cat Belgium Yes Vomit and faeces samples RT‐qPCR 1/1 (100.0) Yes NA WHO (2022)
Cat

New York

State, USA

 Yes Nasal swabs RT‐qPCR 2/2 (100.0) Yes NA Stevanovic et al. (2021); WHO (2022)
Cat Italy Yes Oropharyngeal, nasal, rectal swabs and serum samples RT‐qPCR, PRN 1/22 (4.5) Yes NA Patterson et al. (2020)
Cat Italy Yes Nasal swabs RT‐qPCR 1/1 (100) ND NA Musso et al. (2020)
Cat Spain Yes Nasal, rectal, lung swabs, mesenteric lymph node, nasal turbinates and serum samples RT‐qPCR, serological tests 1/1 (100) Yes NA Segalés et al. (2020)
Cat Wuhan, China No

Oral, rectal swabs

Serum samples

 RT‐qPCR, PRN, serological tests 2/10 (20) Yes NA Chen et al. (2020a)
Cat France Yes Nasopharyngeal, rectal swabs and serum samples RT‐qPCR, serological tests 1/22 (4.5) Yes NA Sailleau et al. (2020)
Cat La Rioja, northern Spain No Oropharyngeal and rectal swabs RT‐qPCR 1/8 (12.5) Yes NA Ruiz‐Arrondo et al. (2021)
Cat Thailand Yes Serum samples Serological tests 4/1112 (0.36) No NA Udom et al. (2022)
Cat France No Serum samples Serological tests 8/34 (23.5) Yes NA Fritz et al. (2020)
Cat Rio de Janeiro, Brazil Yes Nasopharyngeal, oropharyngeal, rectal swabs and serum samples RT‐qPCR, PRN 4/10 (40) Yes NA Calvet et al. (2021)
Cat Brazos, Texas and USA No Nasal/nasopharyngeal, oral/oropharyngeal, rectal, conjunctival swabs and serum samples

RT‐qPCR,

Serological tests

 3/17 (17.6) Yes NA Hamer et al. (2020)
Cat Latin America Yes Nasopharyngeal and rectal samples RT‐qPCR 1/1 (100) Yes 99.4% Carlos et al. (2021)
Cat Italy No Oropharyngeal, nasal and rectal swabs, serum samples RT‐qPCR, serological tests 0/99 (0) Yes NA Stranieri et al. (2021)
Open in a new tab

Abbreviations: COVID‐19, coronavirus disease 2019; NA, not applicable; ND, not determined; PRN, plaque reduction neutralization; RT‐qPCR, reverse transcription quantitative polymerase chain reaction; WHO, World Health Organization.

4. CLINICAL PRESENTATION AND PATHOLOGICAL CHANGES CAUSED BY SARS‐COV‐2 IN PET ANIMALS

SARS‐CoV‐2 can be naturally and experimentally transmitted to dogs and cats, who may or may not develop clinical signs. SARS‐CoV‐2 clinical signs in infected dogs and cats are mild and self‐limiting with mainly respiratory and gastrointestinal manifestations including a combination of any of the following: sneezing, coughing, diarrhoea, anorexia, hyperthermia, lethargy, nasal discharge, regional lymphadenopathy, external otitis, perianal mucosa inflammation, hyperaemic spots on the tongue and bronchopneumonia (Calvet et al., 2021; Sailleau et al., 2020).

At 5 days post infection (DPI), the necropsy of experimentally infected cats with SARS‐CoV‐2 revealed moderate ulcerative, suppurative lymphoplasmacytic rhinitis in the nasal turbinates along with mild lymphoplasmacytic tracheitis and minimal alveolar histiocytosis with oedema (Bosco‐Lauth et al., 2020). The cats which were sacrificed at 28 DPI had moderate lymphoplasmacytic rhinitis with rare fibroplasia. Furthermore, cats which were sacrificed at 42 DPI showed minimal tracheitis, mild rhinitis and mild lung changes, including mild interstitial lymphocytic pneumonia with peribronchiolar and perivascular lymphocytic cuffing and alveolar histiocytosis. The lesions in the upper respiratory tract decreased in cats 42 DPI compared to early time point cats, whereas lung pathology was more evident in cats 42 DPI compared to those scarified during acute infection (Zhou et al., 2020).

Gaudreault et al. (2020) assessed the pathological changes in SARS‐CoV‐2‐experimentally infected cats during 4, 7 and 21 DPI. The respiratory tract showed various degrees of oedema, discoloration, congestion and atelectasis. Pathological changes were limited to the upper and lower airways (larynx, trachea, lobar and segmental bronchi of the lungs), which were characterized by multifocal lymphocytic and neutrophilic tracheobronchoadenitis of seromucous glands of the lamina propria and submucosa of the trachea and bronchi. Changes ranged from minimal to mild at four DPI and mild to moderate at seven DPI. The submucosal glands and associated ducts were distended, lined by attenuated epithelium, contained necrotic cell debris, and had mild to moderate numbers of lymphocytes, macrophages, plasma cells and neutrophilic infiltrations. No significant pathological changes were observed in pulmonary parenchyma of SARS‐CoV‐2‐infected cats on four and seven DPI. No significant pathological changes were observed in the respiratory tract at 21 DPI, with no detectable changes in the submucosa of trachea and bronchi.

5. RECEPTOR UTILIZATION BY SARS‐COV‐2 AND PET SUSCEPTIBILITY TO SARS‐COV‐2

The coronavirus genome encodes 16 major non‐structural proteins (nsp1 to nsp16), and four major structural proteins (Chen et al., 2020b; Helmy et al., 2020; Li, 2016). The spike (S) protein consists of two subunits which are involved in the attachment of the virus to the host cell, membrane fusion and entry into the cell. The S1 subunit amino acids receptor binding domain (RBD) interacts with the angiotensin‐converting enzyme 2 (ACE2) receptor, which is located on the surface of the host cell, to allow binding of the virion with the target cell (Lan et al., 2020; Shang et al., 2020). The S2 subunit promotes virion fusion with the host cell membrane. SARS‐CoV‐2 RBD would not only have affinity for human ACE2 receptors, but also for other animal species, including pets like dogs, cats and ferrets as well as farm animals like cattle, sheep and horses (Sun et al., 2020). The high genetic variability and apparent plasticity of the RBD allow CoVs to bind and subsequently adapt to ACE2 protein receptors of many animal species and increase the probability of the virus to cross species barriers (Andersen et al, 2020). Sequence analysis of the amino acid composition of the ACE2 contacting residues in different mammalian species demonstrated a high degree of similarity between human and feline ACE2 compared to other mammalian ACE2 receptors (Lan et al., 2020). Feline ACE2 has a score of 4, meaning that there were just two conservative substitutions among the 20 interacting residues that were different between feline and human ACE2. Moreover, contacting residues canine ACE2 had a relatively high degree of conservation with scores in the 5–6 range. These findings suggest that the SARS‐CoV‐2 spike is more likely to bind to feline ACE2 than canine ACE2 and this explains why cats are more susceptible to SARS‐CoV‐2 than dogs.

Experimental studies and sporadic reports indicate that dogs and cats are susceptible to SARS‐CoV‐2; however, cats are more susceptible than dogs (Bosco‐Lauth et al., 2020; Shi et al., 2020) and develop a much high neutralizing antibody that prevented reinfection following a second viral challenge (Bosco‐Lauth et al., 2020). Additionally, SARS‐CoV‐2 might be transmitted through respiratory droplets from experimentally inoculated cats to cats with no previous infection after cohoused contact (Halfmann et al., 2020; Shi et al., 2020).

6. PERSISTENCE AND SHEDDING OF SARS‐COV‐2 IN DOGS AND CATS

In experimentally infected dogs, SARS‐CoV‐2 RNA could persist in oropharyngeal and nasopharyngeal samples for 13 days following inoculation (Shi et al., 2020). SARS‐CoV‐2 RNA was detected in rectal swabs of experimentally inoculated cats for up to 14 days post inoculation, while post‐mortem examination clarified that tonsils, lymph node, olfactory pulps and spleen of scarified cats were positive for SARS‐CoV‐2 RNA on 21 days post inoculation with the highest RNA level in tonsils and lymph nodes (Gaudreault et al., 2020). SARS‐CoV‐2 RNA was detected in oropharyngeal and nasopharyngeal samples of naturally infected dogs for 14–31 days after the first positive result (Calvet et al., 2021). In naturally infected cats, SARS‐CoV‐2 RNA could persist in oropharyngeal and nasopharyngeal samples for 8–17 days (Barrs et al., 2020; Newman et al., 2020) and up to 25 days after the first positive result (Hamer et al., 2020).

The viral shedding was evaluated experimentally in earlier studies. Experimentally infected cats with SARS‐CoV‐2 could shed the virus for up to 5 days orally and nasally without developing clinical signs, whereas dogs do not appear to shed virus (Bosco‐Lauth et al., 2020). Nasal and rectal shedding of the virus was evaluated in experimentally inoculated cats with SARS‐CoV‐2 and other non‐infected cats cohoused with inoculated subjects (Halfmann et al., 2020). The authors reported that SARS‐CoV‐2 was detected in nasal swabs of inoculated and cohoused cats and virus shedding lasts for 4–5 days without any evidence of rectal shedding.

7. AUSPICIOUS MODE OF TRANSMISSION OF SARS‐COV‐2 BETWEEN PETS AND OWNERS

To date, there is no epidemiological evidence that dogs and cats could transmit SARS‐CoV‐2 to humans. However, all epidemiological studies indicate that dogs and cats can contract the virus from infected owners or other people who come in to contact with them. The transmission may occur when dogs and cats lick surfaces or fomites contaminated by saliva or respiratory droplets of infected owners emitted during sneezing, coughing or even talking (Ruiz‐Arrondo et al., 2021). Recent observations indicate that SARS‐CoV‐2 might be transmitted from owners to their pets by hand–mouth, eye conjunctiva or touching the nose with hands contaminated by saliva or respiratory droplets (Chen, 2020a). However, the transmission of the virus from infected people to their pets can be facilitated by some favourable risk factors, for example kissing, petting, licking or hugging (Leroy et al., 2020).

8. CROSS‐REACTIVITY BETWEEN SARS‐COV‐2 AND CANINE CORONAVIRUSES AND IMPACT OF PET OWNERSHIP ON THE COURSE OF SARS‐COV‐2

The efficiency of the antibody‐mediated pathway of the host immune system is related to the specificity of the antibody and the capability of the antibody to distinguish between similar and dissimilar antigens. However, the antibody could respond to other antigens similar to the target antigen which may result in cross‐reactivity and effective immunological protection similar to that produced against the primary target (Frank, 2020). A recent study conducted by Tilocca et al. (2020) hypothesized that an immunological cross‐reactivity between SARS‐CoV‐2 and CRCoV exists due to the high homology between the spike protein epitopes of the two taxonomically related CoVs. However, another investigation conducted by Lu et al. (2020) revealed that the nucleocapsid protein of CRCoV and expressed in Escherichia coli displayed antigenic cross reactivity with antisera against human CoVs. According to these findings, recurrent exposure to CCoVs may work as immune‐mobilization against SARS‐COV‐2 by stimulating the human immunological system and providing an effective response to SARS‐COV‐2. Thus, pet owners may contract a mild form of COVID‐19 and be asymptomatic as previously reported in Spain (Jurgiel et al., 2020).

9. RISK FACTORS ASSOCIATED WITH SARS‐COV‐2 INFECTION IN PETS

The main risk factors associated with SARS‐CoV‐2 infection in dogs and cats were close contact of pets (dogs and cats) with COVID‐19‐infected owners through sharing the bed with them as well as neutering of these animals (Calvet et al., 2021). Pets sharing a home with a COVID‐19‐infected person are at a higher risk of being infected with SARS‐CoV‐2 (Fritz et al., 2020).

10. PREVENTIVE AND CONTROL MEASURES

Although there is no evidence that dogs or cats can spread SARS‐CoV‐2 or transmit it to humans, the usual precautionary measures should be urgently considered part of a global control and ‘one health’ approach.

  • Walk dogs on a leash, maintaining at least 6 feet from other people and animals. Avoid dog parks or public places where many people and dogs gather.

  • Wash your pet paws with water and neutral soap or shampoo for animals (such as dog shampoo) before leaving the home.

  • Disinfect bowls, toys and other animal care items with an Environmental Protection Agency‐registered disinfectant and rinse thoroughly with clean water afterwards.

  • Pets that test positive for SARS‐CoV‐2 should be monitored and separated from persons and other animals until they recover.

  • Pet owners without symptoms of COVID‐19 should practice good hygiene through washing their hands before and after interactions with animals and when handling animal food, waste or supplies.

  • Pet owners and every eligible person in the household should be vaccinated.

  • COVID‐19‐infected owners should restrict contact with pets and other people and avoid hugging, petting, kissing, licking, sharing food and sleeping in the same bed with pets.

  • Pet owners suspected or confirmed to have COVID‐19 should avoid close contact with their pets and have another household member who is not infected with SARS‐CoV‐2 take care of them.

  • If a sick pet owner with COVD‐19 must care for their pets, they should wear a mask and wash their hands before and after interacting with them.

  • There is no evidence to date that pets could play a role in the transmission of SARS‐CoV‐2 to humans. Accordingly, there is no reason to remove pets from homes, even if COVID‐19 has been identified in members of the household.

  • There is no scientific evidence that the vaccine used for dogs against CoVs provides cross‐protection against SARS‐CoV‐2; therefore, vaccination against CCoVs does not combat COVID‐19.

11. CONCLUSION

Collectively, epidemiological studies indicate that SARS‐CoV‐2 can be transmitted to dogs and cats through close contact with COVID‐19‐infected owners. However, there is currently no scientific evidence that dogs and cats can transmit SARS‐CoV‐2 to their owners and the COVID‐19 pandemic continues to be driven by human‐to‐human transmission. It is highly crucial to identify the zoonotic link of COVID‐19 and to evaluate the epidemiological involvement of pets in the transmission dynamics of SARS‐CoV‐2 to humans. Additionally, pet owners should apply hygienic measures during contact with their pets, and COVID‐19‐infected owners should limit close contact with pets.

AUTHOR CONTRIBUTIONS

Conceptualization; data curation; supervision; writing – original draft; reviewing and editing : Sina Salajegheh Tazerji and Rasha Gharieb. Formal analysis; writing – original; data curation, writing – original draft: Mohammadreza Manouchehri Ardestani and Farrokhreza Kabir. Data curation; formal analysis: Baharak Akhtardanesh. Conceptualization; data curation: Bita Vazir. Writing – original draft; writing – review and editing: Phelipe Magalhães Duarte. Writing – review and editing: Niloufar Saberi and Sadegh Haerian. Editing: Ehsan Khaksar. Supervision; writing – review and editing: Mohamed Fawzy.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest.

PEER REVIEW

The peer review history for this article is available at https://publons.com/publon/10.1002/vms3.1320.

Salajegheh Tazerji, S. , Gharieb, R. , Ardestani, M. M. , Akhtardanesh, B. , Kabir, F. , Vazir, B. , Duarte, P. M. , Saberi, N. , Khaksar, E. , Haerian, S. , & Fawzy, M. (2024). The risk of pet animals in spreading severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and public health importance: An updated review. Veterinary Medicine and Science, 10, e1320. 10.1002/vms3.1320

DATA AVAILABILITY STATEMENT

The data used to support the findings of this study are available from the corresponding author upon request.

REFERENCES

  1. American Veterinary Medical Association (AVMA) . (2020). SARS‐CoV‐2 in Animals. Available online at: https://www.avma.org/resources‐tools/animal‐health‐and‐welfare/covid‐19/sars‐cov‐2‐animals‐including‐pets
  2. Andersen, K. G. , Rambaut, A. , Lipkin, W. I. , Holmes, E. C. , & Garry, R. F. (2020). The proximal origin of SARS‐CoV‐2. Nature Medicine, 26(4), 450–452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barrs, V. R. , Peiris, M. , Tam, K. W. , Law, P. Y. , Brackman, C. J. , To, E. M. , Yu, V. Y. T. , Chu, D. K. W. , Perera, R. A. P. M. , & Sit, T. H. (2020). SARS‐CoV‐2 in quarantined domestic cats from COVID‐19 households or close contacts, Hong Kong, China. Emerging Infectious Diseases, 26(12), 3071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bogoch, I. I. , Watts, A. , Thomas‐Bachli, A. , Huber, C. , Kraemer, M. U. , & Khan, K. (2020). Pneumonia of unknown aetiology in Wuhan, China: Potential for international spread via commercial air travel. Journal of Travel Medicine, 27(2), taaa008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bosco‐Lauth, A. M. , Hartwig, A. E. , Porter, S. M. , Gordy, P. W. , Nehring, M. , Byas, A. D. , VandeWoude, S. , Ragan, I. K. , Maison, R. M. , & Bowen, R. A. (2020). Experimental infection of domestic dogs and cats with SARS‐CoV‐2: Pathogenesis, transmission, and response to reexposure in cats. Proceedings of the National Academy of Sciences of the United States of America, 117(42), 26382–26388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown, M. A. , Troyer, J. L. , Pecon‐Slattery, J. , Roelke, M. E. , & O'Brien, S. J. (2009). Genetics and pathogenesis of feline infectious peritonitis virus. Emerging Infectious Diseases, 15(9), 1445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buonavoglia, C. , Decaro, N. , Martella, V. , Elia, G. , Campolo, M. , Desario, C. , Castagnaro, M. , & Tempesta, M. (2006). Canine coronavirus highly pathogenic for dogs. Emerging Infectious Diseases, 12(3), 492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Calvet, G. A. , Pereira, S. A. , Ogrzewalska, M. , Pauvolid‐Corrêa, A. , Resende, P. C. , de Souza Tassinari, W. , Costa, A. P. , Keidel, L. O. , da Rocha, A. S. B. , da Silva, M. F. B. , dos Santos, S. A. , Lima, A. B. M. , de Moraes, I. C. V. , Mendes Junior, A. A. V. , Souza, T. D. C. , Martins, E. B. , Ornellas, R. O. , Corrêa, M. L. , Antonio, I. M. D. S. , … Menezes, R. (2021). Investigation of SARS‐CoV‐2 infection in dogs and cats of humans diagnosed with COVID‐19 in Rio de Janeiro, Brazil. PLoS ONE, 16(4), e0250853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carlos, R. S. A. , Mariano, A. P. M. , Maciel, B. M. , Gadelha, S. R. , de Melo Silva, M. , Belitardo, E. M. M. A. , Rocha, D. J. P. G. , de Almeida, J. P. P. , Pacheco, L. G. C. , Aguiar, E. R. G. R. , & Fehlberg, H. F. (2021). First genome sequencing of SARS‐CoV‐2 recovered from an infected cat and its owner in Latin America. Transboundary and Emerging Diseases, 68(6), 3070–3074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chen, J. (2020). Pathogenicity and transmissibility of 2019-nCoVA quick overview and comparison with other emerging viruses. Microbes and Infection, 22(2), 69–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chen, J. , Huang, C. , Zhang, Y. , Zhang, S. , & Jin, M. (2020a). Severe acute respiratory syndrome coronavirus 2‐specific antibodies in pets in Wuhan, China. Journal of Infection, 81(3), 68–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chen, Y. , Liu, Q. , & Guo, D. (2020b). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418–423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cohen, J. I. , Howley, P. M. , & Knipe, D. M. (2013). Fields virology. Wolters Kluwer Health/Lippincott Williams & Wilkins. [Google Scholar]
  14. Decaro, N. , Martella, V. , Elia, G. , Campolo, M. , Desario, C. , Cirone, F. , Tempesta, M. , & Buonavoglia, C. (2007). Molecular characterisation of the virulent canine coronavirus CB/05 strain. Virus Research, 125(1), 54–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Elaswad, A. , Fawzy, M. , Basiouni, S. , & Shehata, A. A. (2020). Mutational spectra of SARS‐CoV‐2 isolated from animals. PeerJ, 8, e10609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Erles, K. , Toomey, C. , Brooks, H. W. , & Brownlie, J. (2003). Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease. Virology, 310(2), 216–223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Frank, S. A. (2020). Immunology and evolution of infectious disease. Princeton University Press. [PubMed] [Google Scholar]
  18. Fritz, M. , Rosolen, B. , Krafft, E. , Becquart, P. , Elguero, E. , Vratskikh, O. , Denolly, S. , Boson, B. , Vanhomwegen, J. , Gouilh, M. A. , & Kodjo, A. (2020). High prevalence of SARS‐CoV‐2 antibodies in pets from COVID‐19+ households. One Health, 11, 100192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gaudreault, N. N. , Trujillo, J. D. , Carossino, M. , Meekins, D. A. , Morozov, I. , Madden, D. W. , … Kwon, T. (2020). SARS‐CoV‐2 infection, disease and transmission in domestic cats. Emerging Microbes & Infections, 9(1), 2322–2332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Halfmann, P. J. , Hatta, M. , Chiba, S. , Maemura, T. , Fan, S. , Takeda, M. , Kinoshita, N. , Hattori, S. , Sakai‐Tagawa, Y. , Iwatsuki‐Horimoto, K. , Imai, M. , & Kawaoka, Y. (2020). Transmission of SARS‐CoV‐2 in domestic cats. New England Journal of Medicine, 383(6), 592–594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hamer, S. A. , Pauvolid‐Corrêa, A. , Zecca, I. B. , Davila, E. , Auckland, L. D. , Roundy, C. M. , Tang, W. , Torchetti, M. , Killian, M. L. , Jenkins‐Moore, M. , & Mozingo, K. (2020). Natural SARS‐CoV‐2 infections, including virus isolation, among serially tested cats and dogs in households with confirmed human COVID‐19 cases in Texas, USA, BioRxiv, 13(5), 416339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Helmy, Y. A. , Fawzy, M. , Elaswad, A. , Sobieh, A. , Kenney, S. P. , & Shehata, A. A. (2020). The COVID‐19 pandemic: A comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. Journal of Clinical Medicine, 9(4), 1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Jaimes, J. A. , Millet, J. K. , Stout, A. E. , André, N. M. , & Whittaker, G. R. (2020). A tale of two viruses: The distinct spike glycoproteins of feline coronaviruses. Viruses, 12(1), 83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jaimes, J. A. , & Whittaker, G. R. (2018). Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function. Virology, 517, 108–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jurgiel, J. , Filipiak, K. J. , Szarpak, Ł. , Jaguszewski, M. , Smereka, J. , & Dzieciątkowski, T. (2020). Do pets protect their owners in the COVID‐19 era? Medical Hypotheses, 142, 109831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kipar, A. , & Meli, M. (2014). Feline infectious peritonitis: Still an enigma? Veterinary Pathology, 51(2), 505–526. [DOI] [PubMed] [Google Scholar]
  27. Lan, J. , Ge, J. , Yu, J. , Shan, S. , Zhou, H. , Fan, S. , Zhang, Q. , Shi, X. , Wang, Q. , Zhang, L. , & Wang, X. (2020). Structure of the SARS‐CoV‐2 spike receptor‐binding domain bound to the ACE2 receptor. Nature, 581(7807), 215–220. [DOI] [PubMed] [Google Scholar]
  28. Leroy, E. M. , Gouilh, M. A. , & Brugère‐Picoux, J. (2020). The risk of SARS‐CoV‐2 transmission to pets and other wild and domestic animals strongly mandates a one‐health strategy to control the COVID‐19 pandemic. One Health, 10, 100133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Li, F. (2016). Structure, function, and evolution of coronavirus spike proteins. Annual Review of Virology, 3(1), 237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Li, Q. , Guan, X. , Wu, P. , Wang, X. , Zhou, L. , Tong, Y. , … Wong, J. Y. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 382(13), 1199–1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Licitra, B. N. , Duhamel, G. E. , & Whittaker, G. R. (2014). Canine enteric coronaviruses: Emerging viral pathogens with distinct recombinant spike proteins. Viruses, 6(8), 3363–3376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lu, R. , Zhao, X. , Li, J. , Niu, P. , Yang, B. , Wu, H. , Wang, W. , Song, H. , Huang, B. , Zhu, N. , Bi, Y. , Ma, X. , Zhan, F. , Wang, L. , Hu, T. , Zhou, H. , Hu, Z. , Zhou, W. , Zhao, L. , … Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. The Lancet, 395(10224), 565–574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Musso, N. , Costantino, A. , La Spina, S. , Finocchiaro, A. , Andronico, F. , Stracquadanio, S. , Liotta, L. , Visalli, R. , & Emmanuele, G. (2020). New SARS‐CoV‐2 infection detected in an Italian pet cat by RT‐qPCR from deep pharyngeal swab. Pathogens, 9(9), 746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Newman, A. , Smith, D. , Ghai, R. R. , Wallace, R. M. , Torchetti, M. K. , Loiacono, C. , Murrell, L. S. , Carpenter, A. , Moroff, S. , Rooney, J. A. , & Barton Behravesh, C. (2020). First reported cases of SARS‐CoV‐2 infection in companion animals—New York, March–April 2020. Morbidity and Mortality Weekly Report, 69(23), 710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Patterson, E. I. , Elia, G. , Grassi, A. , Giordano, A. , Desario, C. , Medardo, M. , Smith, S. L. , Anderson, E. R. , Prince, T. , Patterson, G. T. , Lorusso, E. , Lucente, M. S. , Lanave, G. , Lauzi, S. , Bonfanti, U. , Stranieri, A. , Martella, V. , Solari Basano, F. , Barrs, V. R. , … Decaro, N. (2020). Evidence of exposure to SARS‐CoV‐2 in cats and dogs from households in Italy. Nature Communications, 11(1), 1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pedersen, N. C. (2014). An update on feline infectious peritonitis: Diagnostics and therapeutics. The Veterinary Journal, 201(2), 133–141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Ruiz‐Arrondo, I. , Portillo, A. , Palomar, A. M. , Santibáñez, S. , Santibáñez, P. , Cervera, C. , & Oteo, J. A. (2021). Detection of SARS‐CoV‐2 in pets living with COVID‐19 owners diagnosed during the COVID‐19 lockdown in Spain: A case of an asymptomatic cat with SARS‐CoV‐2 in Europe. Transboundary and Emerging Diseases, 68(2), 973–976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sailleau, C. , Dumarest, M. , Vanhomwegen, J. , Delaplace, M. , Caro, V. , Kwasiborski, A. , Hourdel, V. , Chevaillier, P. , Barbarino, A. , Comtet, L. , Pourquier, P. , Klonjkowski, B. , Manuguerra, J. , Zientara, S. , & Le Poder, S. (2020). First detection and genome sequencing of SARS‐CoV‐2 in an infected cat in France. Transboundary and Emerging Diseases, 67(6), 2324–2328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Salajegheh Tazerji, S. , Magalhães Duarte, P. , Rahimi, P. , Shahabinejad, F. , Dhakal, S. , Singh Malik, Y. , Shehata, A. A. , Lama, J. , Klein, J. , Safdar, M. , Rahman, Md. T. , Filipiak, K. J. , Rodríguez‐Morales, A. J. , Sobur, Md. A. , Kabir, F. , Vazir, B. , Mboera, L. , Caporale, M. , Islam, Md. S. , … Fawzy, M. (2020). Transmission of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) to animals: An updated review. Journal of Translational Medicine, 18(1), 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Segalés, J. , Puig, M. , Rodon, J. , Avila‐Nieto, C. , Carrillo, J. , Cantero, G. , Terrón, M. T. , Cruz, S. , Parera, M. , Noguera‐Julián, M. , Izquierdo‐Useros, N. , Guallar, V. , Vidal, E. , Valencia, A. , Blanco, I. , Blanco, J. , Clotet, B. , & Vergara‐Alert, J. (2020). Detection of SARS‐CoV‐2 in a cat owned by a COVID‐19− affected patient in Spain. Proceedings of the National Academy of Sciences of the United States of America, 117(40), 24790–24793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shang, J. , Ye, G. , Shi, K. , Wan, Y. , Luo, C. , Aihara, H. , Geng, Q. , Auerbach, A. , & Li, F. (2020). Structural basis of receptor recognition by SARS‐CoV‐2. Nature, 581(7807), 221–224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Shi, J. , Wen, Z. , Zhong, G. , Yang, H. , Wang, C. , Huang, B. , Liu, R. , He, X. , Shuai, L. , Sun, Z. , Zhao, Y. , Liu, P. , Liang, L. , Cui, P. , Wang, J. , Zhang, X. , Guan, Y. , Tan, W. , Wu, G. , … Bu, Z. (2020). Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science, 368(6494), 1016–1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sit, T. H. , Brackman, C. J. , Ip, S. M. , Tam, K. W. , Law, P. Y. , To, E. M. , Yu, V. Y. T. , Sims, L. D. , Tsang, D. N. C. , Chu, D. K. W. , Perera, R. A. P. M. , Poon, L. L. M. , & Peiris, M. (2020). Infection of dogs with SARS‐CoV‐2. Nature, 586(7831), 776–778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Stevanovic, V. , Vilibic‐Cavlek, T. , Tabain, I. , Benvin, I. , Kovac, S. , Hruskar, Z. , Mauric, M. , Milasincic, L. , Antolasic, L. , Skrinjaric, A. , & Staresina, V. (2021). Seroprevalence of SARS‐CoV‐2 infection among pet animals in Croatia and potential public health impact. Transboundary and Emerging Diseases, 68(4), 1767–1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sun, J. , He, W.‐T. , Wang, L. , Lai, A. , Ji, X. , Zhai, X. , Li, G. , Suchard, M. A. , Tian, J. , Zhou, J. , Veit, M. , & Su, S. (2020). COVID‐19: Epidemiology, evolution, and cross‐disciplinary perspectives. Trends in Molecular Medicine, 26(5), 483–495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Takano, T. , Kawakami, C. , Yamada, S. , Satoh, R. , & Hohdatsu, T. (2008). Antibody‐dependent enhancement occurs upon re‐infection with the identical serotype virus in feline infectious peritonitis virus infection. Journal of Veterinary Medical Science, 70(12), 1315–1321. [DOI] [PubMed] [Google Scholar]
  47. Tan, W. , Zhao, X. , Ma, X. , Wang, W. , Niu, P. , Xu, W. F. , Gao, G. , & Wu, G. (2020). A novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019− 2020. China CDC Weekly, 2(4), 61–62. [PMC free article] [PubMed] [Google Scholar]
  48. Tilocca, B. , Soggiu, A. , Musella, V. , Britti, D. , Sanguinetti, M. , Urbani, A. , & Roncada, P. (2020). Molecular basis of COVID‐19 relationships in different species: A one health perspective. Microbes and Infection, 22(4–5), 218–220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Udom, K. , Jairak, W. , Chamsai, E. , Charoenkul, K. , Boonyapisitsopa, S. , Bunpapong, N. , Techakriengkrai, N. , & Amonsin, A. (2022). Serological survey of antibodies against SARS‐CoV‐2 in dogs and cats, Thailand. Transboundary and Emerging Diseases, 69(4), 2140–2147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. WHO . (2022). COVID‐19 weekly epidemiological update (99th ed.). WHO. [Google Scholar]
  51. Zhang, Q. , Zhang, H. , Gao, J. , Huang, K. , Yang, Y. , Hui, X. , He, X. , Li, C. , Gong, W. , Zhang, Y. , Zhao, Y. , Peng, C. , Gao, X. , Chen, H. , Zou, Z. , Shi, Z.‐L. , & Jin, M. (2020). A serological survey of SARS‐CoV‐2 in cat in Wuhan. Emerging Microbes & Infections, 9(1), 2013–2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Zhou, P. , Yang, X.‐L. , Wang, X.‐G. , Hu, B. , Zhang, L. , Zhang, W. , Si, H.‐R. , Zhu, Y. , Li, B. , Huang, C.‐L. , Chen, H.‐D. , Chen, J. , Luo, Y. , Guo, H. , Jiang, R.‐D. , Liu, M.‐Q. , Chen, Y. , Shen, X.‐R. , Wang, X. , … Shi, Z.‐L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zhu, N. , Zhang, D. , Wang, W. , Li, X. , Yang, B. , Song, J. , Zhao, X. , Huang, B. , Shi, W. , Lu, R. , Niu, P. , Zhan, F. , Ma, X. , Wang, D. , Xu, W. , Wu, G. , Gao, G. F. , & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727–733. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data used to support the findings of this study are available from the corresponding author upon request.

Articles from Veterinary Medicine and Science are provided here courtesy of Wiley

RESOURCES